Steven Cohen recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Steven A. Cohen is the Chairman and Chief Executive Officer of Point72, a 1,650+ person registered investment advisor. Mr. Cohen founded S.A.C. Capital Advisors in 1992 and converted his investment operations to the Point72 Asset Management family office in 2014.
Cohen received a B.S. in Economics from The Wharton School at the University of Pennsylvania. He began his investing career at Gruntal & Co., where he managed proprietary capital for 14 years before starting his own investment business.
Cohen has leveraged his lengthy career in the public markets to found Point72 Ventures, a global venture capital strategy, and Point72 Hyperscale, a private equity strategy that seeks to drive value creation through applied AI. He also bought the iconic New York Mets major league baseball team in 2020 and serves as Chairman and CEO of the team.
He is an avid philanthropist and entrepreneur alongside his wife and holds active leadership roles in a number of nonprofit organizations.
As of the latest 13F report, the guru’s equity portfolio contained 1341 stocks valued at a total of $23.35Bil. The top holdings were TMUS(1.65%), V(1.17%), and ARGX(0.93%).
According to GuruFocus data, these were Steven Cohen (Trades, Portfolio)’s top five trades of the quarter.
Merrimack Pharmaceuticals Inc
During the quarter, Steven Cohen (Trades, Portfolio) bought 559,296 shares of NAS:MACK for a total holding of 900,981. The trade had a 0.01% impact on the equity portfolio. During the quarter, the stock traded for an average price of $4.26.
On 08/15/2022, Merrimack Pharmaceuticals Inc traded for a price of $4.22 per share and a market cap of $56.59Mil. The stock has returned -12.81% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Merrimack Pharmaceuticals Inc has a price-book ratio of 4.16 and a EV-to-Ebitda ratio of -20.02.
Otonomy Inc
The guru established a new position worth 5,450,000 shares in NAS:OTIC, giving the stock a 0.01% weight in the equity portfolio. Shares traded for an average price of $0.2913 during the quarter.
On 08/15/2022, Otonomy Inc traded for a price of $0.4386 per share and a market cap of $25.00Mil. The stock has returned -70.16% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Otonomy Inc has a price-book ratio of 0.78, a EV-to-Ebitda ratio of -0.14 and a price-sales ratio of 219.30.
Achilles Therapeutics PLC
During the quarter, Steven Cohen (Trades, Portfolio) bought 581,050 shares of NAS:ACHL for a total holding of 2,081,050. The trade had a 0.01% impact on the equity portfolio. During the quarter, the stock traded for an average price of $2.65.
On 08/15/2022, Achilles Therapeutics PLC traded for a price of $3.25 per share and a market cap of $132.52Mil. The stock has returned -49.61% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Achilles Therapeutics PLC has a price-book ratio of 0.48 and a EV-to-Ebitda ratio of 0.86.
T-Mobile US Inc
During the quarter, Steven Cohen (Trades, Portfolio) bought 1,538,646 shares of NAS:TMUS for a total holding of 2,856,455. The trade had a 0.89% impact on the equity portfolio. During the quarter, the stock traded for an average price of $130.44.
On 08/15/2022, T-Mobile US Inc traded for a price of $146.69 per share and a market cap of $183.96Bil. The stock has returned 1.21% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, T-Mobile US Inc has a price-earnings ratio of 107.07, a price-book ratio of 2.60, a price-earnings-to-growth (PEG) ratio of 11.51, a EV-to-Ebitda ratio of 14.33 and a price-sales ratio of 2.29.
The price-to-GF Value ratio is 1.13, earning the stock a GF Value rank of 3.
Booking Holdings Inc
Steven Cohen (Trades, Portfolio) reduced their investment in NAS:BKNG by 90,223 shares. The trade had a 0.85% impact on the equity portfolio. During the quarter, the stock traded for an average price of $2136.85.
On 08/15/2022, Booking Holdings Inc traded for a price of $2129.76 per share and a market cap of $84.56Bil. The stock has returned -3.34% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Booking Holdings Inc has a price-earnings ratio of 56.79, a price-book ratio of 21.37, a EV-to-Ebitda ratio of 27.83 and a price-sales ratio of 5.96.
The price-to-GF Value ratio is 0.76, earning the stock a GF Value rank of 10.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
